Cardiovascular Pharmacology: Open Access

Title Publication Date Language Citations
The Fractal-like Complexity of Heart Rate Variability beyond Neurotransmitters and Autonomic Receptors: Signaling Intrinsic to Sinoatrial Node Pacemaker Cells2013/01/0120
CYP-450 Epoxygenase Derived Epoxyeicosatrienoic Acid Contribute To Reversal of Heart Failure in Obesity-Induced Diabetic Cardiomyopathy via PGC-1α Activation2018/01/0111
Cardio-Ankle Vascular Index (CAVI) and its Potential Clinical Implications for Cardiovascular Disease2013/01/019
Sodium Glucose Transporter 2 (SGLT2) Inhibition does not Protect the Myocardium from Acute Ischemic Reperfusion Injury but Modulates Post- Ischemic Mitochondrial Function2017/01/017
A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK12015/01/016
Switching of Ticagrelor to Clopidogrel at 3 Months in Patients Treated for Acute Care Syndrome; Single Centre Experience2016/01/016
Resolution of Left Ventricular Thrombus after Dabigatran Therapy in Two Patients with Old Anteroseptal Myocardial Infarction2015/01/016
The Probability of Inconstancy in Assessment of Cardiac Function Post- Myocardial Infarction in Mice2016/01/015
ATP Metabolism as Biomarker Target for Cardiovascular Protection2013/01/015
Effects of JNJ-54452840, an Anti-β1 Receptor Antibody Cyclopeptide in Heart Failure Patients: A Randomized, Double-blind, Parallel-group, Phase-2 Pilot Study2016/01/014
Impact of the New P2Y12 Receptor Inhibitors on Mortality in STElevation Myocardial Infarction Patients with Cardiogenic Shock and / or After Cardiopulmonary Resuscitation Undergoing Percutaneous Coronary Intervention2016/01/014
Acenocoumarol in Thromoembolic Disorders2015/01/014
Pharmacological Inhibition of Phosholipase A2: Results from Phase 3 Clinical Trials with Darapladib and Varespladib in Patients with Cardiovascular Disease2015/01/013
Mechanism of Gender-Related Differences in Vascular Function2018/01/013
Recombinant Human Elastase Treatment of Cephalic Veins2016/01/013
Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target2017/01/013
Re-evaluation of Bleeding Events in the Japanese PRASFIT-Elective and PRASFIT-ACS Clinical Trials using the Bleeding Academic Research Consortium Criteria2015/01/013
Supraphysiological Testosterone Levels Shorten the QT Interval but do Not Alter Total Anatomic Myocardial Infarct Size in Rabbits with Acute Myocardial Infarction2014/01/013
A Study of the Effect of Isoproterenol on Red Blood Cell Concentrations of Adenine Nucleotides in a Freely Moving Rat Model In Vivo*2013/01/013
AMP-Activated Protein Kinase Signalling in Cancer and Cardiac Hypertrophy2015/01/012
Dexmedetomidine: The Anesthetic as an Antiarrythmic2015/01/012
Cardio-Oncology: A Tale of Two Diseases2017/01/012
Down Syndrome with Unbalanced Complete Atrioventricular Septal Defect and Truncus Arteriosus2017/01/012
Potential of Monocyte Count for the Assessment of Cardiovascular Disease2017/01/012
Hypertrophic and Inflammatory Markers in Isoproterenol-Induced CardiacHypertrophy and its Pharmacological Correction2017/01/012
MicroRNA Therapeutics for Cardiac Disease2013/01/012
Drugs for the Prevention and Treatment of Cardiac Allograft Vasculopathy2014/01/012
Transhepatic Approach for Device Closure of Secundum Atrial Septal Defect in Patient with Interrupted Inferior Vena Cava2014/01/012
Effect of Vildagliptin, Compared to Sitagliptin, on the Onset of Hyperglycemia-Induced Metabolic Memory in Human Umbilical Vein Endothelial Cells2017/01/012
Endothelial Dysfunction Induced by Chronic Psychological Stress: A Risk Factor for Atherosclerosis2015/01/011